Fundraising Fox

Dr Colin Story

Investor

Advisory Board Member at UK Innovation & Science Seed Fund

About

Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.

Invests in

BiotechMedical Devices

Investments

Board seats

BetaGlue Technologies SpAHox Therapeutics Limited

Per the firm's website.

Colleagues at UK Innovation & Science Seed Fund

Frequently asked questions

Who is Dr Colin Story?
Colin Story joined UKI2S as an advisory board member in November 2023 and has a background in business development within engineering biology organisations. He started his career at GE Healthcare in product development and project management before moving to Isis Innovation, where he built a business development team managing over 200 medical science innovations from Oxford University, and later served as Operations Director at OrganOx. He co-founded OxSonics in 2013 and was its CEO from 2014 to 2022, raising £25m across three rounds.
Where does Dr Colin Story work?
Dr Colin Story is Advisory Board Member at UK Innovation & Science Seed Fund.
What does Dr Colin Story invest in?
Dr Colin Story invests in Biotech, Medical Devices.
What boards does Dr Colin Story sit on?
Dr Colin Story holds tracked board seats at BetaGlue Technologies SpA, Hox Therapeutics Limited.